BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 866 filers reported holding BAXTER INTL INC in Q4 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,398,000 | -16.4% | 73,000 | -3.3% | 0.04% | -23.6% |
| Q2 2015 | $2,868,000 | -83.2% | 75,500 | -69.6% | 0.06% | -85.7% |
| Q1 2015 | $17,033,000 | -85.5% | 248,650 | -84.5% | 0.38% | -86.0% |
| Q4 2014 | $117,337,000 | +8.0% | 1,601,000 | +5.7% | 2.75% | +16.7% |
| Q3 2014 | $108,678,000 | -6.0% | 1,514,250 | -5.4% | 2.36% | -14.8% |
| Q2 2014 | $115,671,000 | -7.7% | 1,599,875 | -6.0% | 2.77% | -16.9% |
| Q1 2014 | $125,261,000 | +12.7% | 1,702,375 | +6.5% | 3.33% | +5.4% |
| Q4 2013 | $111,151,000 | +12915.3% | 1,598,150 | +12193.5% | 3.16% | +12061.5% |
| Q3 2013 | $854,000 | +193.5% | 13,000 | +209.5% | 0.03% | +188.9% |
| Q2 2013 | $291,000 | -4.6% | 4,200 | 0.0% | 0.01% | -25.0% |
| Q1 2013 | $305,000 | +82.6% | 4,200 | +68.0% | 0.01% | +33.3% |
| Q4 2012 | $167,000 | -95.8% | 2,500 | -96.6% | 0.01% | -99.0% |
| Q1 2011 | $3,979,000 | +15.6% | 74,000 | +8.8% | 0.86% | -8.2% |
| Q4 2010 | $3,442,000 | – | 68,000 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 53,850,000 | $2,054,378,000 | 20.84% |
| Smithwood Advisers, L.P. | 1,000,000 | $38,150,000 | 10.54% |
| SECTOR GAMMA AS | 937,600 | $35,769,000 | 9.19% |
| Smithwood Advisers, L.P. | 500,000 | $19,075,000 | 5.27% |
| Veritas Asset Management LLP | 10,592,749 | $404,113,000 | 5.07% |
| York Capital Management Global Advisors, LLC | 7,887,822 | $300,921,000 | 4.47% |
| Iguana Healthcare Management, LLC | 325,000 | $12,399,000 | 4.08% |
| Osher Van de Voorde Investment Management | 174,160 | $6,644,000 | 3.82% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $7,630,000 | 3.22% |
| Governors Lane LP | 600,000 | $22,890,000 | 3.22% |